McKesson's QCDR status allows direct data submission to CMS via iKnowMed EHR, enhancing oncology practice efficiency. Practice Insights supports reporting of nine oncology-specific QCDR measures ...

Foundation has received a generous gift to establish the David & Tara Ruberg HVI Innovation and Research Center of ...

Larry Robbins is an American hedge fund manager, philanthropist, and the founder, CEO, and portfolio manager of Glenview ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of $650.00. The company’s shares closed yesterday at ...

Citi lowered the firm’s price target on McKesson (MCK) to $677 from $713 and keeps a Buy rating on the shares as part of a 2025 outcook for the health technology and distribution group.

Tuesday closed up +0.72%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.30%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.26%. March E-mini S&P futures (ESH25) rose by +0.68%, and ...

Jan. 7—There will be new life at the former McKesson plant in Shenango Township. CSI Container Services Inc. will relocate from its current location at 209 Green Ridge Road in Neshannock ...

Jan. 30, 2025 — A study suggests that a computer-generated breathing coach could be as effective as sessions with a human ...